The Patent Finder

Genaera Corporation

Also on record
Records under this name other than the patents Genaera Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Back to Genaera Corporation

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,981,876Polymorphic and amorphous salt forms of squalamine dilactate
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,716,270Polymorphic and amorphous salt forms of squalamine dilactate
Formerly held
Lapsed on the fee record
Ended May 6, 2026 · USPTO record
Lapsed on the fee recordEnded May 6, 2026USPTO record
US 7,728,157Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterols
Formerly held
Lapsed on the fee record
Ended Jun 1, 2022 · USPTO record
Lapsed on the fee recordEnded Jun 1, 2022USPTO record
US 7,074,778Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
Formerly held
Term ended
Term ended May 30, 2021 · USPTO record
Term endedTerm ended May 30, 2021USPTO record
US 6,933,383Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterols
Formerly held
Term ended
Term ended Apr 12, 2021 · USPTO record
Term endedTerm ended Apr 12, 2021USPTO record
US 7,410,959Therapeutic uses for aminosterol compounds
Formerly held
Lapsed on the fee record
Ended Aug 12, 2020 · USPTO record
Lapsed on the fee recordEnded Aug 12, 2020USPTO record
US 9,365,608Method for treating diabetes
Formerly held
Lapsed on the fee record
Ended Jun 14, 2020 · USPTO record
Lapsed on the fee recordEnded Jun 14, 2020USPTO record
US 6,261,559Methods of treating asthma with interleukin-9 antibodies
Term ended
Term ended Jun 4, 2019 · USPTO record
Term endedTerm ended Jun 4, 2019USPTO record
US 7,056,698Nucleic acids encoding interleukin-9 receptor variants
Term ended
Term ended Nov 2, 2018 · USPTO record
Term endedTerm ended Nov 2, 2018USPTO record
US 6,610,866Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds
Formerly held
Term ended
Term ended Mar 22, 2018 · USPTO record
Term endedTerm ended Mar 22, 2018USPTO record
10 of 52 patents shown.
Pro members see all 52.
Pro members: see all 52 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited